Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,022 | -2,508 | -9,445 | -7,585 | -5,533 |
| Depreciation Amortization | 1,465 | 322 | 879 | 572 | 346 |
| Accounts receivable | 1 | 19 | -32 | -10 | -14 |
| Accounts payable and accrued liabilities | -178 | -69 | 186 | 410 | 216 |
| Other Working Capital | 309 | 223 | 821 | 1,101 | 666 |
| Other Operating Activity | 2,226 | 854 | 3,737 | 3,018 | 2,334 |
| Operating Cash Flow | $-2,199 | $-1,158 | $-3,854 | $-2,494 | $-1,985 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | N/A | -4 | N/A | N/A |
| Investing Cash Flow | $-13 | $N/A | $-4 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,474 | 421 | 2,542 | 1,385 | 875 |
| Debt Repayment | -149 | -120 | -330 | -114 | -74 |
| Common Stock Issued | 439 | 414 | 2,080 | 1,199 | 1,169 |
| Other Financing Activity | 0 | 0 | -15 | -7 | -15 |
| Financing Cash Flow | $1,763 | $715 | $4,277 | $2,463 | $1,955 |
| Beginning Cash Position | 452 | 452 | 32 | 32 | 32 |
| End Cash Position | 4 | 9 | 452 | 1 | 2 |
| Net Cash Flow | $-448 | $-443 | $420 | $-31 | $-30 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,199 | -1,158 | -3,854 | -2,494 | -1,985 |
| Capital Expenditure | -13 | N/A | -4 | N/A | N/A |
| Free Cash Flow | -2,212 | -1,158 | -3,857 | -2,494 | -1,985 |